Sulzer launches new biodegradable polymer
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Evinova will operate as a separate health-tech business within AstraZeneca
Decision on EU marketing authorisation expected for momelotinib by early 2024
Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
The companies plan to start a pivotal Phase 3 trial in the coming months
In the Phase 3 LIBRETTO-431 study, Retevmo more than doubled progression-free survival (PFS) compared to chemotherapy plus pembrolizumab in patients with advanced or metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC)
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Subscribe To Our Newsletter & Stay Updated